Abstracts Archive - Page 420 of 1683 - ATC Abstracts

2020 American Transplant Congress
Liver Live Donor Champion: Advocacy Training to Facilitate Identification of Live Liver Donors
A. D. Love¹, L. R. Herbst¹, D. R. Helfer¹, L. Kurman², M. G. Bowring¹, S. R. Weeks¹, E. King¹, D. L. Segev¹, J. Garonzik Wang¹
¹Surgery, The Johns Hopkins School of Medicine, Baltimore, MD, ²Surgery, The Johns Hopkins Hospital, Baltimore, MD
*Purpose: Although live donor liver transplantation (LDLT) may help address organ shortage, patients lack knowledge about living donation and are reluctant to speak to potential…
2020 American Transplant Congress
Unified Management of Inferior Vena Cava Web and Right Hepatic Vein in Living Donor Liver Transplantation for Membranous Obstruction of Vena Cava (Budd Chiari Syndrome)
Y. Nah, S. Park, E. Lee, S. Park
Department of Surgery, Ulsan University Hospital, Ulsan, Korea, Republic of
*Purpose: In Eastern countries Budd Chiari syndrome (BCS) is most often caused by the membranous obstruction of the vena cava (MOVC). During living donor liver…
2020 American Transplant Congress
A Single-Center Experience in Transfusion-Free Liver Transplantation: Referrals and Outcomes from 2005 to 2019
B. H. Horwich¹, A. Mulgaonkar¹, B. Kim², N. Kaur¹, J. Kahn², Y. Genyk³, A. Ahearn³, H. Han²
¹Internal Medicine, University of Southern California, Los Angeles, CA, ²GI & Liver Diseases, University of Southern California, Los Angeles, CA, ³Surgery, University of Southern California, Los Angeles, CA
*Purpose: The Jehovah’s Witnesses is a religious group known to the medical community for its non-acceptance of blood products. This poses a significant challenge in…
2020 American Transplant Congress
Steatosis Quantification by MRI PDFF Effectively Identifies Liver Allografts at Low Risk for Recipient Complicationsin Living Donor Liver Transplantation
A. Duarte-Rojo, D. R. Jorgensen, Q. Qi, K. Chupetlovska, A. A. Borhani, A. Furlan, M. Molinari, S. Ganesh, A. Humar
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Novel methods to assess steatosis, such as proton density fat fraction (PDFF) from MRI provide an accurate and continuous quantification of mild steatosis. We…
2020 American Transplant Congress
Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation
E. Palte¹, J. Duong², H. Remotti³, J. Burt³, A. Griesemer⁴, B. Samstein⁵, D. Marratta⁶, A. N. Fox⁷
¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY, ²Columbia University Mailman School of Public Health, New York, NY, ³Department of Pathology and Cell Biology, Columbia University, New York, NY, ⁴Department of Surgery, Columbia University, New York, NY, ⁵Department of Surgery, Weill Cornell Medicine, New York, NY, ⁶Department of Medicine, Columbia University, New York, NY, ⁷Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY
*Purpose: Living donor liver transplantation (LDLT) increases the donor pool and affords a life-saving cure to recipients who do not have MELD-based access to allografts.…
2020 American Transplant Congress
Validation of the Graft Volume Formula Avoiding Small-for-Size Graft Dysfunction in Adult to Adult Living Donor Liver Transplantation
A. Nishimagi, N. Sato, Y. Kofunato, T. Ishigame, R. Okada, T. Kimura, A. Kenjo, S. Marubashi
Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukishima Medical University, Fukushima, Japan
*Purpose: It is important to determine the optimal volume of liver graft in living donor liver transplantation(LDLT) for avoiding small-for-size graft syndrome(SFSS) A formula of…
2020 American Transplant Congress
Analysis of Factors Affecting Postoperative Hepatic Volume Increase in Liver Donor
J. Cho, K. Lee, S. Hong, J. Lee, E. Han, K. Hong, N. Yi, K. Suh
Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: In living donor liver transplantation, donor safety is the top priority.Thus, the debate over how much a donor’s liver can be taken to recipient…
2020 American Transplant Congress
Lowering Meld, Diminishing Length of Stay, and Increasing Liver Transplant Numbers Comes Through the Generosity of Others: Declined HCV-NAT Offers Subsequently Transplanted Have Excellent Outcomes
R. Gilroy, S. Sell, J. Krong, A. Gagnon, I. Zendejas, S. Fujita, M. Rodriguez, D. Alonso
Transplant Services, Intermountain Healthcare, Murray, UT
*Purpose: There is variability between programs in the acceptance of organ offers. This paper examines offer, acceptance and program performance with HCV NAT positive donor…
2020 American Transplant Congress
Steroids Ameriplate the Progression of Calcineurin Inhibitors Nephrotoxicity in Kidney Allografts
N. Iwahara¹, H. Sasaki², D. Iwami¹, K. Hotta¹, Y. Takada¹, H. Higuchi², T. Tanabe², N. Shinohara¹
¹Hokkaido University, Sapporo, Japan, ²Sapporo City General Hospital, Sapporo, Japan
*Purpose: Although calcineurin inhibitors (CNI) lead to excellent short-term kidney allograft outcome, chronic nephrotoxicity is a major concern which affects long-term allograft survival. It has…
2020 American Transplant Congress
Peritoneal Dialysis in Delayed Graft Function, a Safe and Effective Option
A. Gardezi, B. Muth, F. Aziz, N. Garg, M. Mohamed, A. Djamali, D. Mandelbrot, S. Parajuli
University of Wisconsin, Madison, WI
*Purpose: Peritoneal dialysis (PD) has been utilized increasingly in the past decade. Many of these patients undergo transplantation and may require dialysis for delayed graft…